Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |